1-3 of 3
Johnnatan Tamayo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained FVIII Expression with a Tolerable, Titratable, Fully Non-Viral Gene Therapy for Hemophilia a

Johannes Schwerk, Mauricio Barajas-Mora, Hua Wang, Brian Truong, Michael Bennett, Nicholas Cam, James Clancey, Alicia Davis, Khal Hajj, Bonnie Jacques, Johnnatan Tamayo, James Yen, Joshua Rychak, Blair Madison
Journal: Blood
Blood (2024) 144 (Supplement 1): 7462.
https://doi.org/10.1182/blood-2024-211223
Published: 2024
Journal Articles

Effective Gene Therapy for Hemophilia a: Novel Re-Dosable Non-Viral Formulation That Provides Stable, and Durable FVIII Expression with Improved Tolerability

Brian Truong, Khal Hajj, Johannes Schwerk, Dongyang Zhang, Johnnatan Tamayo, Gizem Guzelsoy, Joseph Kubicki, Alicia Davis, Lijun Huang, Gopi Vemuri, Kevin Johnson, Dan Smith, Jordan Bendor, Mu Li, Manjunath Goolyam, Daniel Abernathy, Pranav Nyshadham, Fernando Espinoza, Michelle Burrascano, James Yen, Kevin Briseno, Min Tong, Jen Beck, Joseph Lucas, Pavan Battiprolu, Michael Bennett, Blair Madison, Brent Warner, Eric Ostertag, Joshua Rychak
Journal: Blood
Blood (2023) 142 (Supplement 1): 1232.
https://doi.org/10.1182/blood-2023-189784
Published: 2023
Journal Articles

Sustained Factor VIII Activity Following Single Dose of Non-Viral Integrating Gene Therapy

Brian Truong, Giang N. Nguyen, Khal Hajj, Joseph Lucas, Johannes Schwerk, James Yen, Kevin Briseno, Michelle Burrascano, Daniel Smith, Johnnatan Tamayo, Fernando Lopez-Espinoza, Michael Bennett, Blair Madison, Denise E. Sabatino, Joshua Rychak
Journal: Blood
Blood (2022) 140 (Supplement 1): 969–970.
https://doi.org/10.1182/blood-2022-167919
Published: 2022